Cancer CXC chemokine networks and tumour angiogenesis

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
R M StrieterJohn A Belperio

Abstract

Chemokines have pleiotropic effects in regulating immunity, angiogenesis, stem cell trafficking, and mediating organ-specific metastases of cancer. In the context of angiogenesis, the CXC chemokine family is a unique group of cytokines known for their ability to behave in a disparate manner in the regulation of angiogenesis. The glutamic acid-leucine-arginine (ELR+) CXC chemokines are potent promoters of angiogenesis, and mediate their angiogenic activity via signal-coupling of CXCR2 on endothelium. By contrast, members of the CXC chemokine family, such as platelet factor-4 (PF4; CXCL4) and interferon-inducible CXC chemokines are potent inhibitors of angiogenesis, and use CXCR3 on endothelium to mediate their angiostatic activity. This review will discuss the biology of CXC chemokines in the context of angiogenesis related to cancer.

References

Jan 1, 1991·Pharmacology & Therapeutics·R AuerbachI Polakowski
Mar 1, 1988·Chest·B R Zetter
May 1, 1994·The Journal of Experimental Medicine·D R SmithR M Strieter
Sep 1, 1994·Pharmacology & Therapeutics·W Auerbach, R Auerbach
Nov 10, 1995·The Journal of Biological Chemistry·R M StrieterD Marriott
Feb 1, 1995·Archives of Otolaryngology--head & Neck Surgery·R F CohenD L Kreutzer
Dec 1, 1995·American Journal of Respiratory and Critical Care Medicine·A YuanK T Luh
Jun 15, 1996·The Journal of Clinical Investigation·D A ArenbergR M Strieter
Apr 17, 1997·Nature·W Risau
May 1, 1997·Oncology·G GastlA Kraft
Jul 1, 1997·Klinische Pädiatrie·M HotfilderJ E Wolff
Nov 28, 1997·American Journal of Surgery·B L RichardsD L Kreutzer
Feb 12, 1998·Science·T Pawson, J D Scott
Feb 12, 1998·The New England Journal of Medicine·A D Luster
Feb 14, 1998·Cancer Practice·Y F Hui, R J Ignoffo
Mar 11, 1998·Journal of Viral Hepatitis·F Balkwill
Mar 24, 1998·Annual Review of Medicine·B R Zetter
Apr 1, 1998·Journal of the National Cancer Institute·J YonedaI J Fidler
May 12, 1998·Circulation Research·W Risau
May 23, 1998·Annual Review of Immunology·S GhoshE B Kopp
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·H SotoA Zlotnik
Aug 6, 1998·The Journal of Clinical Investigation·D A ArenbergR M Strieter
May 18, 1999·The American Journal of Pathology·B B MooreR M Strieter
Jun 15, 2000·The American Journal of Pathology·M J FrederickG L Clayman
Oct 12, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R SalcedoJ J Oppenheim
Mar 29, 2001·Nature Immunology·B Moser, P Loetscher
Apr 12, 2002·International Journal of Cancer. Journal International Du Cancer·Andrew L FeldmanH Richard Alexander
Apr 16, 2002·British Journal of Cancer·A J SchraderJ Lauber
Sep 5, 2002·Nature Reviews. Immunology·Ann Richmond
Mar 11, 2003·American Journal of Respiratory and Critical Care Medicine·Roderick J PhillipsRobert M Strieter
Nov 26, 2003·International Journal of Cancer. Journal International Du Cancer·Henry Q XiongKeping Xie
Jun 15, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jinming Yang, Ann Richmond

❮ Previous
Next ❯

Citations

Aug 30, 2008·Cell and Tissue Research·William C Aird
Apr 25, 2012·Clinical Oral Investigations·Silky Rajesh Punyani, Ramhari Shankarrao Sathawane
Sep 11, 2007·Cancer Metastasis Reviews·Seema SinghRakesh K Singh
Aug 25, 2007·Cancer Metastasis Reviews·Simi Ali, Gwendal Lazennec
Apr 15, 2010·Cancer Metastasis Reviews·Albert R DavalosPierre-Yves Desprez
Sep 25, 2007·Clinical & Experimental Metastasis·Adit Ben-Baruch
Feb 10, 2009·Clinical & Experimental Metastasis·Stefania GelminiClaudio Orlando
Jun 15, 2011·Investigational New Drugs·Juliana RomaniniMaria M Campos
Jul 4, 2012·Journal of Molecular Histology·Qingchao ZhuYu Wang
Jun 15, 2011·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Zhixin CaoJianping Gong
Jun 28, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Remi-Martin LabergePierre-Yves Desprez
Jan 26, 2007·Nature Reviews. Cancer·Robert T Dorsam, J Silvio Gutkind
Sep 11, 2008·Proceedings of the National Academy of Sciences of the United States of America·Emmanouil D Karagiannis, Aleksander S Popel
Feb 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Martin AugstenArne Ostman
Jul 31, 2013·The Journal of Experimental Medicine·Laura RaccostaVincenzo Russo
Mar 14, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Jiannong LiEric B Haura
Sep 26, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M R Sandhya RaniRichard M Ransohoff
Jun 14, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G LurjeH-J Lenz
Oct 2, 2009·Carcinogenesis·S J MoghaddamBurton F Dickey
Apr 13, 2012·Anti-cancer Drugs·Elena Victoria RoscaJohn Laterra
Jan 15, 2010·Journal of Oncology·Francois P Duhoux, Jean-Pascal Machiels
Nov 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anne M SchultheisHeinz-Josef Lenz
May 28, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gong YangJinsong Liu
Aug 12, 2010·Molecular Cancer Therapeutics·Rupal S BhattJames W Mier
Aug 28, 2012·The Journal of Clinical Investigation·Thomas JamiesonOwen J Sansom
Jun 27, 2008·BMC Cancer·Claudia RubieMartin K Schilling
May 6, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John YeeStephen Lam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.